Corrigendum: Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models

Front Mol Biosci. 2016 Nov 18:3:75. doi: 10.3389/fmolb.2016.00075. eCollection 2016.

Authors

Roberta Coroniti¹, Rafal Farjo², Didier J Nuno², Laszlo Otvos³, Laura Scolaro¹, Eva Surmacz¹

Affiliations

¹ Sbarro Institute for Cancer Research and Molecular Medicine, Temple University Philadelphia, PA, USA.
² Department of Biology, Temple University Philadelphia, PA, USA.
³ EyeCRO Oklahoma, OK, USA.

Abstract

[This corrects the article on p. 67 in vol. 3, PMID: 27790618.].

Keywords: ObR antagonist; VEGF; leptin; ocular neoangiogenesis; peptide drug.

Publication types

Published Erratum